Short Summary

Detection of breast cancer at home. The company's goal is to design, manufacture and sell smart clothing to detect and prevent resident cancers, in particular breast cancer.


Investment Raised
Previous Rounds 90'000CHF
Stage Pre-Startup/R&D
Investor Role Monthly Involvement


  • The internal team is assembled and ready as well as the industrial partner
  • We are supported by specialist doctors
  • We own the IP
  • The traction and interest of the project was confirmed at two exhibitions
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
14% raised

Eadie Technologies Inc.

location_on Nova Scotia, Canada

Eadie Technologies Inc has developed a new gold standard system for glaucoma diagnosis and monitoring; previously raised $500K with 10 ophthalmologist investors; optical & mechanical designs complete; prototype complete; patent filed; MVP by Jan 2021

480'000 CHF


6'900 CHF

Min per Investor

Global Pro
100% raised

The Future of Cannabis

location_on Victoria, Australia

Montu is providing patients with access to life-changing cannabis medication through a growing nationwide network of doctors. Changing cannabis legislation has opened a new chapter in healthcare with access to safer and healthier medication.

1'300'000 CHF


660 CHF

Min per Investor

Global Pro
5% raised


location_on South East, USA

Eight out of ten strokes are preventable with proper care. We are integrating remote patient monitoring, AI, and telemedicine in order to make expert-level, preventative stroke care accessible to the millions of underserved at-risk patients.

450'000 CHF


22'000 CHF

Min per Investor

load one similar proposal

This website uses cookies to personalize and deliver appropriate content, analyze website traffic and display advertising. By clicking "Accept" you agree to our terms and may continue to use this website. Visit our cookie policy to learn more. ×